These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2330118)

  • 1. Terminal component of complement (C9) in the cerebrospinal fluid of patients with multiple sclerosis and neurologic controls.
    Rodriguez M; Wynn DR; Kimlinger TK; Katzmann JA
    Neurology; 1990 May; 40(5):855-7. PubMed ID: 2330118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terminal component of complement (C9) in cerebrospinal fluid of patients with multiple sclerosis.
    Morgan BP; Campbell AK; Compston DA
    Lancet; 1984 Aug; 2(8397):251-4. PubMed ID: 6146808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terminal component of complement C9 in CSF and plasma of patients with MS and aseptic meningitis.
    Halawa I; Lolli F; Link H
    Acta Neurol Scand; 1989 Aug; 80(2):130-5. PubMed ID: 2816275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid C9 in demyelinating disease.
    Compston DA; Morgan BP; Oleesky D; Fifield R; Campbell AK
    Neurology; 1986 Nov; 36(11):1503-6. PubMed ID: 3762967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C9 in multiple sclerosis.
    Patterson V
    Lancet; 1984 Aug; 2(8400):458. PubMed ID: 6147518
    [No Abstract]   [Full Text] [Related]  

  • 6. A haemolytic assay for the measurement of C9 in human serum and cerebrospinal fluid.
    Asghar SS; Siem H; van der Helm HJ
    Clin Chim Acta; 1987 Jun; 165(2-3):387-90. PubMed ID: 3652460
    [No Abstract]   [Full Text] [Related]  

  • 7. Elevation of human cerebrospinal fluid clusterin concentration is associated with acute neuropathology.
    Polihronis M; Paizis K; Carter G; Sedal L; Murphy B
    J Neurol Sci; 1993 Apr; 115(2):230-3. PubMed ID: 8387101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoradiometric assay for human complement component C9 utilising monoclonal antibodies.
    Morgan BP; Campbell AK; Luzio JP; Siddle K
    Clin Chim Acta; 1983 Oct; 134(1-2):85-94. PubMed ID: 6652914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic complement profiling in multiple sclerosis as a biomarker of disease state.
    Ingram G; Hakobyan S; Hirst CL; Harris CL; Loveless S; Mitchell JP; Pickersgill TP; Robertson NP; Morgan BP
    Mult Scler; 2012 Oct; 18(10):1401-11. PubMed ID: 22354735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression.
    Albanese M; Zagaglia S; Landi D; Boffa L; Nicoletti CG; Marciani MG; Mandolesi G; Marfia GA; Buttari F; Mori F; Centonze D
    J Neuroinflammation; 2016 Feb; 13():36. PubMed ID: 26863878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels.
    Calabrese V; Scapagnini G; Ravagna A; Bella R; Foresti R; Bates TE; Giuffrida Stella AM; Pennisi G
    J Neurosci Res; 2002 Nov; 70(4):580-7. PubMed ID: 12404512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acid.
    Vrethem M; Mattsson E; Hebelka H; Leerbeck K; Osterberg A; Landtblom AM; Balla B; Nilsson H; Hultgren M; Brattström L; Kågedal B
    Mult Scler; 2003 Jun; 9(3):239-45. PubMed ID: 12814169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid nitrate levels in patients with multiple sclerosis.
    de Bustos F; Navarro JA; de Andrés C; Molina JA; Jiménez-Jiménez FJ; Ortí-Pareja M; Gasalla T; Tallón-Barranco A; Martínez-Salio A; Arenas J
    Eur Neurol; 1999 Jan; 41(1):44-7. PubMed ID: 9885328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Level of sFas/APO 1 in serum and cerebrospinal fluid in multiple sclerosis.
    Mahovic D; Petravic D; Petelin Z; Zurak N; Horvat G; Hajnsek S
    Clin Neurol Neurosurg; 2004 Jun; 106(3):230-2. PubMed ID: 15177773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of complement in neurodevelopmental impairment following neonatal hypoxic-ischemic encephalopathy.
    Aly H; Khashaba MT; Nada A; Hasanen BM; McCarter R; Schultz SJ; Gordon L; Feldhoff PW; Lassiter HA
    Am J Perinatol; 2009 Oct; 26(9):659-65. PubMed ID: 19391086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocytochemical localization of the terminal complement complex in multiple sclerosis.
    Compston DA; Morgan BP; Campbell AK; Wilkins P; Cole G; Thomas ND; Jasani B
    Neuropathol Appl Neurobiol; 1989; 15(4):307-16. PubMed ID: 2779734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of vitronectin and activated complement factor C9 on ventriculoperitoneal shunts and temporary ventricular drainage catheters.
    Lundberg F; Li DQ; Falkenback D; Lea T; Siesjö P; Söderström S; Kudryk BJ; Tegenfeldt JO; Nomura S; Ljungh A
    J Neurosurg; 1999 Jan; 90(1):101-8. PubMed ID: 10413162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical value of commonly used spinal fluid diagnostic studies in the evaluation of patients with suspected multiple sclerosis.
    Brasher GW; Follender AB; Spiekerman AM
    Am J Manag Care; 1998 Aug; 4(8):1119-21. PubMed ID: 10182887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the cause and nature of C9-related heterogeneity of terminal complement complexes generated on target erythrocytes through the action of whole serum.
    Bhakdi S; Tranum-Jensen J
    J Immunol; 1984 Sep; 133(3):1453-63. PubMed ID: 6747293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Growth hormone levels in the blood serum and cerebrospinal fluid of patients with multiple sclerosis].
    Nowak S; Kowalski D; Kowalska K; Błaszczyk B; Banasinska E
    Neurol Neurochir Pol; 1987; 21(4-5):315-8. PubMed ID: 3444500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.